Investigation of the Effect of Nigella Sativa Oil and Sesame Oil in Preventing Phlebitis
Launched by KUTAHYA HEALTH SCIENCES UNIVERSITY · Sep 6, 2023
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is investigating whether two natural oils, Nigella sativa oil (black seed oil) and sesame oil, can help prevent phlebitis, which is inflammation of the veins often caused by intravenous (IV) treatments. Phlebitis can lead to pain, swelling, and redness at the site of the IV, especially when certain medications, like amiodarone, are given through the catheter. The study aims to find out if applying these oils can reduce the chances of developing phlebitis in patients receiving IV amiodarone.
To participate in this trial, you need to be at least 18 years old, currently receiving IV amiodarone, and have a specific type of IV catheter placed in your arm. Participants should be able to understand Turkish and agree to take part voluntarily. However, you won't be eligible if you already have phlebitis, certain allergies, or other medical conditions that could complicate the study. If you join, you can expect to apply one of the oils and help researchers determine if these oils can make IV treatments safer and more comfortable for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years and over,
- • IV amiodarone treatment was started,
- • PIC applied to the cephalic or basilic vein,
- • Number 20 catheter is preferred in PIC application,
- • At least primary school graduate and can speak Turkish,
- • Patients who voluntarily agree to participate in the study will be included in the study.
- Exclusion Criteria:
- • Diagnosed with active phlebitis,
- • Having a diagnosis of mental illness or communication problems,
- • Hearing and vision problems,
- • Skin integrity is impaired,
- • Having a body temperature above 38.5 Cº,
- • Stating that he is allergic to sesame oil and black cumin oil,
- • Receiving irritant medication or liquid other than Amiodarone through the catheter,
- • Receiving long-term IV therapy from cephalic or basilic veins,
- • Mastectomy surgery, fistula,
- • who have been diagnosed with SVO,
About Kutahya Health Sciences University
Kutahya Health Sciences University is a premier academic institution dedicated to advancing healthcare through innovative research and clinical trials. Committed to fostering excellence in medical education and patient care, the university collaborates with leading researchers and healthcare professionals to conduct cutting-edge studies aimed at improving health outcomes. With a focus on translating scientific discoveries into practical applications, Kutahya Health Sciences University plays a vital role in shaping the future of healthcare through rigorous clinical research and interdisciplinary collaboration.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Merkez, Kütahya, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported